FIELD: organic chemistry.
SUBSTANCE: invention relates to 1-((6-bromoquinolin-4-yl)thio)cyclobutane-1-carboxylate of formula (I). Invention also relates to a crystalline form of the compound of formula (I), a method of producing a compound of formula (I) and a crystalline form thereof, pharmaceutical composition based on the compound of formula (I) or its crystalline form, as well as use of the compound of formula (I) or its crystalline form.
EFFECT: obtaining a novel compound, including in a crystalline form, useful in treating a disease associated with a uric acid transporter (URAT1).
7 cl, 2 dwg, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTAL OF AZOLE BENZENE DERIVATIVE | 2015 |
|
RU2675854C2 |
| AZOBENZENE DERIVATIVE AND CRYSTALLINE FORM THEREOF | 2015 |
|
RU2701515C2 |
| CRYSTAL FORM AND SALT 3-(3,5-DICHLORO-4-HYDROXYBENZOIL)- 1,1-DIOXO-2,3-DIHYDRO-1,3-BENZOTHIAZOLE | 2018 |
|
RU2772043C2 |
| CRYSTALLINE FORM OF A BRUTON'S TYROSINE KINASE INHIBITOR AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2728827C2 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
| AMINE SALT AND CRYSTALS THEREOF | 2013 |
|
RU2658823C2 |
| TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
| CRYSTALLINE FORM OF COMPOUND USED AS A MINERALOCORTICOID RECEPTOR ANTAGONIST AND THE METHOD OF ITS PRODUCTION | 2013 |
|
RU2622105C2 |
| CRYSTALLINE POLYMORPHYL OF 4-[5-(PYRIDINE-4-YL)-1H-1,2,4-TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE AND METHOD OF ITS OBTAINING | 2013 |
|
RU2639149C2 |
| CRYSTAL FORM OF THE PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE | 2017 |
|
RU2793759C2 |
